Antiparasitic agent atovaquone.
Baggish
Aaron L
AL
University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Hill
David R
DR
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D053626:Atovaquone; D001403:Babesia / Q000187:drug effects; D006801:Humans; D009285:Naphthoquinones / Q000494:pharmacology / Q000627:therapeutic use*; D010961:Plasmodium / Q000187:drug effects; D011010:Pneumocystis / Q000187:drug effects; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy*; D011528:Protozoan Infections / Q000188:drug therapy* / Q000469:parasitology; D016032:Randomized Controlled Trials as Topic; D014122:Toxoplasma / Q000187:drug effects
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D053626:Atovaquone